Email ID
Password
Scrip   
Starpharma secures A$15.6 million for VivaGel programme
20 November 2009
Christopher Spillane

The Australian firm Starpharma has raised A$15.6 million ($14.5 million) to fund a clinical programme for its lead product, VivaGel, in bacterial vaginosis.

The private placement offered 30 million shares at A$0.52 each and was led by Orbis, an existing investor in the company. Starpharma's...



Please Login to read the full article.
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36